Recent research at the Stony Brook University Cancer Center has revealed that Avastin, the cancer drug, increases the risk of blood clots in the veins by some 33% when it is taken together with chemotherapy.
The study was published in The Journal of the American Medical Association and looked at 15 previous clinical trials involving a total of nearly 8,000 persons. It found that Avastin, which is marketed by Roche and Genentech, increased the risk of blood clots from about 10% to about 13%.
Dr Shenhong Wu, leader of the study, said that this is “a significant increased risk with Avastin for patients while they are taking chemotherapy”.
Related posts:
- Older Folks, Who Are More Likely To Get Cancer, Are In Fact Mostly Excluded From Clinical Trials Fact: The majority, or about 60%, of people who are...
- Vast Majority of Oncologists Would NOT Use Chemotherapy If They Got Cancer Would you allow a car mechanic who does not know...
- Chemotherapy Does Not Work, Is Costly, Has Adverse Effects, And Kills So what's this about chemotherapy (and radiation)? What's this about...
- Cancer Drugs Used To Shrink Tumors In Fact Promote Their Growth In conventional cancer treatment, the focus is almost totally on...
- Possible Way In Which Meat Increases Cancer Risk Numerous studies have already linked the consumption of meat, in...